Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
The nuclear factor-kappaB (NF-κB) signaling pathway is considered as a potential
therapeutic target in cancer therapy. It has been well established that transcription factor NF …
therapeutic target in cancer therapy. It has been well established that transcription factor NF …
(Nano) platforms in breast cancer therapy: drug/gene delivery, advanced nanocarriers and immunotherapy
Breast cancer is the most malignant tumor in women, and there is no absolute cure for it.
Although treatment modalities including surgery, chemotherapy, and radiotherapy are …
Although treatment modalities including surgery, chemotherapy, and radiotherapy are …
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
Cancer cells frequently display intrinsic or acquired resistance to chemically diverse
anticancer drugs, limiting therapeutic success. Among the main mechanisms of this …
anticancer drugs, limiting therapeutic success. Among the main mechanisms of this …
[HTML][HTML] Molecular targets, therapeutic agents and multitasking nanoparticles to deal with cancer stem cells: A narrative review
There is increasing evidence that malignant tumors are initiated and maintained by a sub-
population of tumor cells that have similar biological properties to normal adult stem cells …
population of tumor cells that have similar biological properties to normal adult stem cells …
Molecular modeling strategies of cancer multidrug resistance
G Yalcin-Ozkat - Drug Resistance Updates, 2021 - Elsevier
Cancer remains a leading cause of morbidity and mortality worldwide. Hence, the increase
in cancer cases observed in the elderly population, as well as in children and adolescents …
in cancer cases observed in the elderly population, as well as in children and adolescents …
In silico and in vitro screening of 50 curcumin compounds as EGFR and NF-κB inhibitors
MEM Saeed, R Yücer, M Dawood, MEF Hegazy… - International Journal of …, 2022 - mdpi.com
The improvement of cancer chemotherapy remains a major challenge, and thus new drugs
are urgently required to develop new treatment regimes. Curcumin, a polyphenolic …
are urgently required to develop new treatment regimes. Curcumin, a polyphenolic …
Medicinal plants and phytochemicals against multidrug-resistant tumor cells expressing ABCB1, ABCG2, or ABCB5: a synopsis of 2 decades
Multidrug resistance is a major factor causing the failure of cancer chemotherapy. Efflux
pumps of the ATP-binding cassette (ABC) transporter family expel a large array of diverse …
pumps of the ATP-binding cassette (ABC) transporter family expel a large array of diverse …
Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell
Z Yang, X Yang, Y Li, Y Cai, Y Yu, W Zhuang… - European Journal of …, 2023 - Elsevier
The co-administration of anticancer drugs and P-glycoprotein (P-gp) inhibitors was a
treatment strategy to surmount multidrug resistance (MDR) in anticancer chemotherapy. In …
treatment strategy to surmount multidrug resistance (MDR) in anticancer chemotherapy. In …
Multidrug resistance in cancer cells: focus on a possible strategy plan to address colon carcinoma cells
Even though various treatment methods are available for cancer, the death curve is not
reducing. The diagnosis of cancer at the fourth stage and drug resistance are the leading …
reducing. The diagnosis of cancer at the fourth stage and drug resistance are the leading …
ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C
Aims To investigate the collateral sensitivity (CS) of ABCB1-positive multidrug resistant
(MDR) colorectal cancer cells to the survivin inhibitor MX106–4C and the mechanism …
(MDR) colorectal cancer cells to the survivin inhibitor MX106–4C and the mechanism …